What changed in this filing

/stocks — the workspaceLOADING

Item 5. Other Information

2022-08-08 compared with 2022-05-09 · 17 added, 20 removed, 17 unchanged (69% of the section changed)

Incorporation

Amendment to License Agreement, dated October 14, 2021, made by and among Lipocine Inc., and Antares Pharma, Inc.

Accounting Officer Employment Agreement, dated March 7, 2022, by and between Lipocine Inc.

and Krista Fogarty.

Certification

of Principal Executive Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002

Certification

of Principal Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002

Certification

of Principal Executive Officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, 18 U.S.C.

Certification

of Principal Financial Officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, 18 U.S.C.

Amended and Restated Certificate of Incorporation

Certificate of Designation of Series A Junior Participating Preferred Stock

Certificate of Increase of Series A Junior Participating Preferred Stock (incorporated by reference to Exhibit 3.1 to the Company’s Current Report on Form 8-K filed with the SEC on November 1, 2021).

Certificate of Amendment to the Amended and Restated Certificate of Incorporation of Lipocine, Inc.

License Agreement, dated October 14, 2021, by and between Lipocine Inc.

and Antares Pharma, Inc.

First Amendment to License Agreement, dated April 1, 2022, made by and among Lipocine Inc., and Antares Pharma, Inc.

Certification of Principal Executive Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002

Certification of Principal Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002

Certification of Principal Executive Officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, 18 U.S.C.

Certification of Principal Financial Officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, 18 U.S.C.

Instance Document - the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within

6 unchanged sentences

Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101)

Management contract or compensation

plan or arrangement

treatment has been granted with respect to certain portions of this exhibit.

1 unchanged sentence

the Securities and Exchange Commission.

certification accompanies the Form 10-Q to which it relates, is not deemed filed with the

Securities and Exchange Commission and is not to be incorporated by reference into any filing

of the Registrant under the Securities Act, or the Exchange Act (whether made before or after

the date of the Form 10-Q), irrespective of any general incorporation language contained

in such filing.

certification accompanies the Form 10-Q to which it relates, is not deemed filed with the Securities and Exchange Commission and

is not to be incorporated by reference into any filing of the Registrant under the Securities Act, or the Exchange Act (whether made

before or after the date of the Form 10-Q), irrespective of any general incorporation language contained in such filing.

to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by

the undersigned thereunto duly authorized.

August 8, 2022

Patel, President and Chief

Executive Officer)

Krista Fogarty

August 8, 2022

Fogarty, Corporate Controller

Accounting Officer)

Financial and Accounting Officer)

Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.

What changed 10-Q

Item 5. Other Information